Results 121 to 130 of about 90,622 (332)

Childhood primary cutaneous non-T/non-B lymphoma followed by acute T-cell leukemia [PDF]

, 1986
Thomas T. Tang, Stephen J. Lauer, Joseph M. Harb, Phyllis A. Kirchner, Stuart Adair, Bruce M. Camitta   +5 more
openalex   +1 more source

Cutaneous T-Cell Lymphomas [PDF]

JAMA Dermatology, 2017
Julia Dai, Timothy Almazan, Youn H. Kim
openaire   +3 more sources

Compliance of Dermatology Screening Visits Among Patients With Skin Cancer‐Predisposing Pathogenic Variants

JEADV Clinical Practice, EarlyView.
Patients with genetic variants that increase skin cancer risk are recommended to undergo regular dermatology screenings per National Comprehensive Cancer Network guidelines, but compliance is uncertain. In a retrospective study of 230 patients with such variants, compliance with screening visits significantly improved after visiting a Hereditary Cancer
Stephen J. Gadomski, Kevin S. Hughes, Jihad S. Obeid, Courtney Rowley, Graciela De Jesús   +4 more
wiley   +1 more source

Novel cell adhesion/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T cell lymphoma [PDF]

, 2019
BACKGROUND: Treatment for Cutaneous T Cell Lymphoma (CTCL) is generally not curative. Therefore, selecting therapy that is effective and tolerable is critical to clinical decision-making. Histone deacetylase inhibitors (HDACi), epigenetic modifier drugs,
Andrews, Jared M, Carson, Kenneth R, Mehta-Shah, Neha, Musiek, Amy C, Payton, Jacqueline E, Schmidt, Jennifer A   +5 more
core   +2 more sources

Delayed Time to First Skin Cancer Among Hematopoietic Stem Cell Transplant Recipients With Chronic Cutaneous Graft‐Versus‐Host Disease

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Hematopoietic stem cell transplant (HSCT) recipients face an increased risk of cutaneous malignancies. Chronic cutaneous graft‐versus‐host disease (cGVHD), specific to allogeneic HSCT (alloHSCT), has been proposed to further elevate this risk, though its impact on skin cancer latency and distribution remains unclear.
Amy J. Petty, Vanessa Lazaro‐Camp, Melodi Javid Whitley   +2 more
wiley   +1 more source

A case of primary cutaneous CD8+ aggressive epidermotropic cytotoxic T‐cell lymphoma

JEADV Clinical Practice
A 65‐year‐old Japanese woman with primary cutaneous CD8+ aggressive epidermotropic cytotoxic T‐cell lymphoma, a rare type with a poor prognosis, is presented.
Tomomichi Shimizu, Nobuhiro Takahashi, Aya Okaniwa, Reiko Saito, Akio Kondoh, Fumikazu Yamazaki, Shunsuke Nagase, Naoya Nakamura, Kazuya Takeuchi, Tomotaka Mabuchi   +9 more
doaj   +1 more source

Mycosis Fungoides: A Diagnostic Challenge

International Journal of Medical Students, 2022
Background: Mycosis fungoides (MF) is the most frequent type of cutaneous T-cell lymphomas (CTCL), a heterogeneous group of non-Hodgkin lymphoma of T-cell origin. CTCLs accounts for about 4% of all non-Hodgkin lymphoma.
Siddhartha Nath, Arunima Dhabal, Indrashis Podder   +2 more
doaj  

Natural antibodies to the human T cell lymphoma virus in patients with cutaneous T cell lymphomas. [PDF]

, 1981
L E Posner, Marjorie Robert-Guroff, V. S. Kalyanaraman, Bernard J. Poiesz, Francis W. Ruscetti, Byron E. Fossieck, Paul A. Bunn, John D. Minna, Robert C. Gallo   +8 more
openalex   +1 more source

Extreme Peripheral Blood Plasmacytosis Mimicking Plasma Cell Leukemia as a Presenting Feature of Angioimmunoblastic T-Cell Lymphoma (AITL). [PDF]

, 2019
Angioimmunoblastic T-cell lymphoma (AITL) is one of four major subtypes of nodal peripheral T cell lymphoma, characterized by its cell of origin, the follicular helper T-cell (TFH).
Alpdogan, Onder, Gong, Jerald Z., Haverkos, Bradley M., Johnson, William T., Kartan, Saritha, Nikbakht, Neda, Porcu, Pierluigi, Sokol, Kelsey   +7 more
core   +1 more source

Never say never

Journal of Hospital Medicine, EarlyView.
Gurpreet Dhaliwal, Jagmeet Dhingra, Tom Fraser, Leal Herlitz, James Pile   +4 more
wiley   +1 more source